These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 22991725)

  • 21. Discontinuation syndrome in dysthymic patients treated with selective serotonin reuptake inhibitors: a clinical investigation.
    Bogetto F; Bellino S; Revello RB; Patria L
    CNS Drugs; 2002; 16(4):273-83. PubMed ID: 11945110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paroxetine treatment of trichotillomania in an adolescent.
    Block C; West SA; Baharoglu B
    J Child Adolesc Psychopharmacol; 1998; 8(1):69-71. PubMed ID: 9639081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Female sexual side effects associated with selective serotonin reuptake inhibitors: a descriptive clinical study of 33 patients.
    Shen WW; Hsu JH
    Int J Psychiatry Med; 1995; 25(3):239-48. PubMed ID: 8567191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serotonin toxicity caused by an interaction between fentanyl and paroxetine.
    Rang ST; Field J; Irving C
    Can J Anaesth; 2008 Aug; 55(8):521-5. PubMed ID: 18676387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Safety of selective serotonin reuptake inhibitor antidepressants in children and adolescents].
    Bailly D
    Presse Med; 2006 Oct; 35(10 Pt 2):1507-15. PubMed ID: 17028514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Possible serotoninergic syndrome associated with coadministration of paroxetine and tramadol].
    Llinares-Tello F; Escrivá-Moscardó S; Martínez-Pastor F; Martínez-Mascaraque P
    Med Clin (Barc); 2007 Mar; 128(11):438. PubMed ID: 17394862
    [No Abstract]   [Full Text] [Related]  

  • 27. Neonatal symptoms following maternal paroxetine treatment: serotonin toxicity or paroxetine discontinuation syndrome?
    Haddad PM; Pal BR; Clarke P; Wieck A; Sridhiran S
    J Psychopharmacol; 2005 Sep; 19(5):554-7. PubMed ID: 16166193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Dose-escalation of SSRIS in major depressive disorder. Should not be recommended in current guidelines].
    Ruhé HG; Booij J; van Weert HC; Reitsma JB; Franssen EJ; Michel MC; Schene A
    Tijdschr Psychiatr; 2010; 52(9):615-25. PubMed ID: 20862644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential effects of milnacipran, fluvoxamine and paroxetine for depression, especially in gender.
    Morishita S; Arita S
    Eur Psychiatry; 2003 Dec; 18(8):418-20. PubMed ID: 14680720
    [No Abstract]   [Full Text] [Related]  

  • 30. Paroxetine for the treatment of depression: a critical update.
    Gibiino S; Serretti A
    Expert Opin Pharmacother; 2012 Feb; 13(3):421-31. PubMed ID: 22263916
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spotlight on paroxetine in psychiatric disorders in adults.
    Wagstaff AJ; Cheer SM; Matheson AJ; Ormrod D; Goa KL
    CNS Drugs; 2002; 16(6):425-34. PubMed ID: 12027788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brief report: paroxetine in younger and adult individuals at high risk for suicide.
    Bauer MS; Wisniewski SR; Kogan JN; Marangell LB; Thase ME; Sachs G
    Psychopharmacol Bull; 2006; 39(1):31-7. PubMed ID: 17065973
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Case Report of Serotonin Syndrome in a Patient on Selective Serotonin Reuptake Inhibitor (SSRI) Monotherapy.
    Hudd TR; Blake CS; Rimola-Dejesus Y; Nguyen TT; Zaiken K
    J Pharm Pract; 2020 Apr; 33(2):206-212. PubMed ID: 31030620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Chronic cough under treatment with paroxetine].
    Hamel H; Bonniaud P; Sgro C; Foucher P; Camus P
    Presse Med; 2000 May 27-Jun 3; 29(19):1045. PubMed ID: 10874912
    [No Abstract]   [Full Text] [Related]  

  • 35. [Comparative efficacy and tolerability of paroxetine and amitriptiline in long-term therapy preventing depressive recurrences].
    Mosolov SN; Kostiukova EG; Gorodnichev AV; Timofeev IV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(10):22-9. PubMed ID: 16281375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paroxetine and congenital malformations: meta-Analysis and consideration of potential confounding factors.
    Bar-Oz B; Einarson T; Einarson A; Boskovic R; O'Brien L; Malm H; Bérard A; Koren G
    Clin Ther; 2007 May; 29(5):918-926. PubMed ID: 17697910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spontaneous ecchymoses due to paroxetine administration.
    Cooper TA; Valcour VG; Gibbons RB; O'Brien-Falls K
    Am J Med; 1998 Feb; 104(2):197-8. PubMed ID: 9528740
    [No Abstract]   [Full Text] [Related]  

  • 38. Combination of paroxetine and rasagiline induces serotonin syndrome in a parkinsonian patient.
    Hébant B; Guillaume M; Desbordes M; Gaillon G; Maltête D; Lefaucheur R
    Rev Neurol (Paris); 2016 Dec; 172(12):788-789. PubMed ID: 27838092
    [No Abstract]   [Full Text] [Related]  

  • 39. An imperfect literature and evidence-based medicine.
    Freeman MP
    J Clin Psychiatry; 2009 Mar; 70(3):412-3. PubMed ID: 19317958
    [No Abstract]   [Full Text] [Related]  

  • 40. [Withdrawal syndrome caused by selective serotonin reuptake inhibitors: apropos of a case].
    Bryois C; Rubin C; Zbinden JD; Baumann P
    Praxis (Bern 1994); 1998 Mar; 87(10):345-8. PubMed ID: 9545842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.